Ritu Singh

4PUBLICATIONS
3CO-AUTHORS
Nanotoxicology, health and safetyMolecular medicineTraditional Chinese medicine and treatmentsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 08, 2026
Short-Term HbA1c Non-Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic Interchangeability.

|Feb 04, 2022
Letter by Awadhesh Kumar Singh Regarding Article, "Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis".

Awadhesh Kumar Singh, Ritu Singh

|Aug 02, 2021
Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes.

Awadhesh K Singh, Ritu Singh, Partha Pratim Chakraborty

|Apr 01, 2021
Do SGLT-2 inhibitors exhibit similar cardiovascular benefit in patients with heart failure with reduced or preserved ejection fraction?

Awadhesh Kumar Singh, Ritu Singh, Anoop Misra

Pageof 1

Frequent Collaborators

4 joint publications

Awadhesh Kumar Singh

1 joint publications

Anoop Misra

1 joint publications

Akriti Singh